Dr. Miver Erem Tokuş
NeurosurgeryVerified
- 24+years exp.
English · Turkish
FromPrice on request
Free quote
60 seconds · no obligationView Profile
Neurological Diagnostics
Brain fdg-pet
What a brain FDG-PET scan is, how fluorodeoxyglucose maps cerebral glucose metabolism, and what clinical evidence confirms for dementia differentiation, refractory epilepsy, and brain tumours. This guide covers how brain FDG-PET compares with MRI and amyloid PET, approximate costs in Turkey against the UK, US, and Germany, scan preparation, what results indicate, safety, and choosing a certified diagnostic centre.
A written plan with the surgeon's name and the full price — usually within 24 hours.
- Category
- Neurological Diagnostics
- Hospitals
- 2
- Verified
- 1
- Price from
- Price on request
Verified surgeons for Brain FDG-PET
1 doctor Compare doctors, ratings and prices — ask any of them for a free quote.
Brain FDG-PET in Turkey: what it is and how it works
Brain FDG-PET (fluorodeoxyglucose positron emission tomography) is a specialised diagnostic scan that measures regional glucose metabolism across the living brain. Brain cells rely almost entirely on glucose for cellular energy. When neurological disorders such as dementia, epilepsy, or tumours develop, regional glucose consumption changes long before structural damage or tissue shrinkage appears on conventional scans. By injecting a minute amount of radiolabelled glucose, brain FDG-PET creates a detailed three-dimensional map showing where brain tissue is functioning normally, where metabolic activity is abnormally low (hypometabolism), and where it is abnormally high.
Brain FDG-PET is not a general wellness check; it is a targeted examination requested by neurologists and neurosurgeons. It is primarily used to differentiate dementia subtypes, locate epileptic seizure foci, and distinguish recurrent brain tumours from post-treatment scarring. This guide explains how the scan works, what clinical evidence confirms, approximate costs in Turkey compared with the UK, US, and Germany, and what to expect during your diagnostic trip. For patients undergoing wider neurological investigations, see our guide to neurosurgery treatments in Turkey.
How does a brain FDG-PET scan work?
The human brain represents only two percent of body weight but consumes roughly twenty percent of resting whole-body glucose. A brain FDG-PET scan uses 18F-fluorodeoxyglucose (18F-FDG), a glucose analogue biologically tagged with the positron-emitting isotope fluorine-18 produced in a medical cyclotron.
The scan proceeds through three precise biological and physical stages:
- Tracer injection and metabolic trapping: The tracer is injected into a vein and crosses the blood-brain barrier via glucose transporter proteins. Brain cells absorb it, and the enzyme hexokinase phosphorylates it into 18F-FDG-6-phosphate. Because it cannot undergo further glycolysis, it remains trapped inside active cells in direct proportion to their glucose consumption rate.
- Positron annihilation: As the fluorine-18 isotope decays, it emits positrons that collide with nearby electrons in tissue. This annihilation produces pairs of 511 keV gamma rays travelling in opposite directions.
- Image detection: The PET-CT scanner rings detect these gamma-ray pairs simultaneously, allowing computer algorithms to reconstruct precise cross-sectional metabolic maps of the brain.
Does brain FDG-PET imaging work, and what does the clinical evidence show?
Clinical research and guidelines from professional bodies, including the European Association of Nuclear Medicine (EANM) and the Society of Nuclear Medicine and Molecular Imaging (SNMMI), confirm that brain FDG-PET is highly effective for defined neurological questions.
Clinical evidence is strongest across three core clinical indications:
- Differentiating dementia types: Studies confirm diagnostic accuracy exceeding eighty-five percent in distinguishing Alzheimer's disease from frontotemporal dementia and dementia with Lewy bodies. Each neurodegenerative condition damages distinct neural networks, creating identifiable metabolic patterns.
- Localising epilepsy foci: In drug-resistant focal epilepsy where magnetic resonance imaging (MRI) is normal or equivocal, interictal FDG-PET identifies areas of reduced metabolism corresponding to the seizure origin in sixty to eighty percent of cases.
- Evaluating brain tumours: FDG-PET reliably differentiates active high-grade tumour recurrence from radiation necrosis following radiotherapy.
Conversely, clinical evidence highlights definite boundaries. The scan is not a population screening test for healthy individuals concerned about memory, cannot replace a histological biopsy for tumour grading, and yields unreliable images if blood glucose is elevated prior to injection.
Clinical conditions evaluated with brain FDG-PET
Neurologists and neurosurgeons utilise brain FDG-PET across three primary clinical fields: cognitive disorders, refractory epilepsy, and neuro-oncology.
In cognitive decline, the scan reveals specific patterns of cellular metabolic failure: Alzheimer's disease typically causes reduced metabolism in the posterior cingulate and temporoparietal cortices, frontotemporal lobar degeneration targets the frontal and anterior temporal lobes, and dementia with Lewy bodies affects the occipital visual cortex. In epilepsy presurgical evaluation, metabolic imaging is frequently correlated with EEG electroencephalography to match electrical seizure onset with areas of reduced glucose metabolism between seizures. In neuro-oncology, it helps neurosurgeons locate the most active tumour zones for biopsy and differentiates radiation-induced tissue scarring from true tumour recurrence.
Brain FDG-PET cost in Turkey compared with the UK, US and Germany
The figures below reflect approximate outpatient cost ranges per examination, not specific hospital quotes. Prices vary based on scanner technology, cyclotron radiotracer transport, and specialist reporting requirements.
| Country | Approximate cost range |
|---|---|
| Turkey | €600 – €1,600 |
| United Kingdom | €1,400 – €3,200 |
| United States | €2,200 – €5,500 |
| Germany | €1,200 – €2,800 |
Factors that influence the final price include whether PET-CT or PET-MRI is used, whether low-dose contrast is required, and whether an expert dual-read neuroradiology report with statistical software comparison is included. In Turkey, diagnostic packages typically include the radiotracer dose, scan acquisition, specialist physician report, digital imaging files on disc, hospital transfers, and language assistance.
Brain FDG-PET, brain MRI, or amyloid PET imaging?
Each imaging modality examines a different aspect of brain health. While a structural scan reveals physical lesions and EEG electroencephalography records electrical activity, FDG-PET identifies functional metabolic abnormalities.
| Modality | Best suited to | Typical limits |
|---|---|---|
| Brain FDG-PET | Mapping glucose hypometabolism in dementia subtypes, locating seizure foci, and assessing tumour recurrence | Functional metabolic map without fine tissue microanatomy; requires radiotracer injection and fasting |
| Brain MRI (structural) | High-resolution anatomical images, detecting acute stroke, tumours, hydrocephalus, and measuring brain atrophy | May appear normal in early neurodegenerative stages and non-lesional epilepsy; cannot track active glucose metabolism |
| Amyloid PET | Detecting beta-amyloid plaques to confirm or rule out Alzheimer's disease pathology | Detects protein plaques only; does not assess neuronal metabolic dysfunction or non-amyloid dementias |
In clinical practice, these tools complement each other. Neurologists typically begin with structural MRI to rule out tumours or vascular strokes, followed by FDG-PET if metabolic function needs clarification. Diagnostic hospitals in Turkey work alongside multidisciplinary teams specialising in neurology and neurosurgery treatments in Turkey.
Who is a suitable candidate, and who should delay the scan?
Good candidates include adults with unexplained, progressive memory or cognitive decline where MRI findings are inconclusive, patients with drug-resistant focal epilepsy undergoing pre-surgical assessment, and brain tumour patients needing differentiation between recurrence and radiation injury. Candidates must be able to lie still on the scanner bed for twenty to thirty minutes.
You should delay or reconsider the scan if you are pregnant, because radioactive tracers pose risks to a developing fetus. If your blood glucose is above 160 to 200 mg/dL (8.9 to 11.1 mmol/L), the scan must be postponed because excess glucose competes with the tracer and degrades image quality. Patients who have had an acute seizure within twenty-four to forty-eight hours should reschedule to avoid misleading postictal metabolic changes. Breastfeeding mothers must express and discard milk for twelve to twenty-four hours after the injection.
The scanning procedure step by step: preparation, injection, and imaging
A brain FDG-PET examination is an outpatient procedure lasting about two to three hours from arrival to discharge:
- Fasting and preparation: You must fast for four to six hours before the scan, drinking only plain water. Strenuous exercise and caffeine are avoided for twenty-four hours.
- Blood sugar check: Upon arrival, staff verify your fasting status and check capillary blood glucose via a finger prick. A small intravenous cannula is inserted into your arm.
- Tracer injection and quiet uptake: The 18F-FDG tracer is administered. You then rest quietly in a dimly lit, silent room for thirty to forty-five minutes without talking, reading, using your phone, or chewing, preventing unwanted cortical stimulation.
- Image acquisition: You lie on the scanner couch with your head supported in a padded cradle. A brief CT scan maps tissue density, followed by fifteen to twenty-five minutes of PET acquisition. You simply breathe normally and remain still.
Your trip to Turkey and brain FDG-PET recovery step by step
Because the scan is non-invasive and requires no surgical incisions, physical recovery is immediate. Most international patients visit Turkey for two to three days.
On day one, you arrive and attend any preliminary consultations. On day two, you complete your fasting scan in the morning. After imaging, you can eat immediately and resume regular activities. Drinking 1.5 to 2 litres of water throughout the day accelerates tracer clearance through the kidneys. As a standard safety precaution, avoid close contact with pregnant women and infants for twelve hours. On day three, your specialist written report and digital imaging disc are delivered, followed by a neurologist review before you fly home.
Risks, radiation exposure, and safety of brain FDG-PET
Brain FDG-PET is a safe, well-established examination. Independent health authorities including the NHS, the European Association of Nuclear Medicine, and the US Food and Drug Administration confirm that serious adverse events are exceedingly rare.
The total radiation dose from the tracer and low-dose CT is typically 3 to 5 millisieverts (mSv), roughly equivalent to one to two years of natural background radiation. The injected 18F-FDG contains only nanogram amounts of substance, so it has no chemical or sedative effect on the body and does not cause drowsiness or nausea. Allergic reactions are exceptionally rare. Minor bruising may occasionally occur at the cannula site, resolving in a few days. Patients with severe claustrophobia can receive mild oral sedation under medical supervision.
How to choose a diagnostic centre in Turkey and questions to ask
Choose a licensed hospital or dedicated imaging centre equipped with a modern PET-CT system and a nuclear medicine department experienced in neurological evaluations. Ensure reports are interpreted by board-certified nuclear medicine specialists or neuroradiologists.
Red flags include clinics that do not test blood glucose before injection, conduct tracer uptake in noisy waiting areas, refuse to provide full raw DICOM data, or offer quotes with hidden fees for tracer delivery or radiologist reporting.
Questions to ask your diagnostic coordinator:
- What model of PET-CT scanner is used, and what is its resolution?
- Is the report authored by a consultant specialising in brain imaging?
- Will my results include comparison with an age-matched normative database?
- What happens if my blood glucose is elevated on the morning of the scan?
- Do I receive complete digital DICOM files on disc or USB?
Read about how it works when arranging specialist diagnostic imaging abroad. You can request a preliminary assessment and package details through our free quote page: our coordinators review your records and provide a clear written plan.
Hospitals with Neurosurgery in Turkey
Frequently asked questions
A brain FDG-PET scan is an advanced nuclear medicine imaging test that measures regional glucose metabolism in the brain. A tiny amount of radioactive fluorodeoxyglucose is injected into the bloodstream. Because brain cells use glucose for energy, areas with impaired function show reduced uptake, helping specialists identify patterns of neurological disease.
Yes, it is clinically validated and endorsed by international neurological guidelines. For cognitive decline, it accurately distinguishes Alzheimer's disease from frontotemporal dementia or dementia with Lewy bodies. In drug-resistant focal epilepsy, it identifies regions of interictal hypometabolism, pinpointing seizure origin zones when MRI scans show normal anatomy.
A brain FDG-PET scan in Turkey generally costs between €600 and €1,600, compared with €1,400 to €3,200 in the UK and up to €5,500 in the US. The price covers the radiotracer, PET-CT scanner acquisition, a formal specialist neuroradiology report, and digital image delivery on disc or cloud.
Scan results provide detailed functional metabolic maps rather than photographic images. Comparing scans before and after neurological treatment or surgical resection shows whether glucose metabolism has stabilised, normalised, or changed. In neuro-oncology, post-treatment scans clearly distinguish active tumour recurrence with high metabolism from radiation-induced tissue necrosis with low metabolism.
There is no prolonged physical recovery period because the scan is non-invasive and requires no incisions. Patients leave the hospital immediately after the acquisition finishes. Drinking plenty of water over the next twenty-four hours accelerates urinary excretion of the tracer. Patients should avoid prolonged close physical contact with pregnant women and infants for twelve hours.
The scan does not cause physical pain. The only minor discomfort is a standard needle prick when the intravenous line is placed in your arm. During imaging, you lie still on a padded scanner bed with your head supported by a comfortable cradle inside an open-ended scanner ring for twenty to thirty minutes.
A specialist nuclear medicine physician and neuroradiologist typically complete the comprehensive report within twenty-four to forty-eight hours. The metabolic map represents your baseline brain function at the time of scanning and remains a valid clinical diagnostic reference until significant new neurological symptoms emerge or treatment is altered.
Yes. The radiation dose from a brain FDG-PET examination is low, typically between 3 and 5 millisieverts. According to the NHS and European Association of Nuclear Medicine, this exposure is comparable to approximately one to two years of natural background radiation, and the short half-life isotope decays rapidly.
Brain MRI produces fine anatomical images showing physical structures, brain atrophy, tumours, and vascular strokes. In contrast, brain FDG-PET reveals metabolic cellular activity. In early dementia and non-lesional epilepsy, metabolic dysfunction visible on PET often precedes structural shrinkage visible on MRI by several years, making the two modalities highly complementary.
Most patients stay in Turkey for two to three days. This timeline allows for an initial pre-scan medical consultation, blood glucose verification, the scanning session, and a follow-up review with a neurologist once the detailed radiotracer reconstruction and radiologist report are finalised.
Patient stories